Blood Markers of Early Pancreas Cancer identifier:
NCT03568630 (

Observational study for people with family history of pancreas cancer or an inherited mutation linked to pancreatic cancer risk.

Study Contact Information:

For additional information, please contact: Suzanne Wessling, RN by phone: 402-559-1577 or by email: [email protected] or
Kelsey A Klute, MD by phone: 402-559-8500 or by email

About the Study

The purpose of this study is to try to find markers of early pancreatic cancer for individuals at higher-than-average risk, expedite the diagnosis in individuals with symptoms, and substantially improve an individual's chance of surviving the disease. 

What the Study Entails

Each study participant will undergo blood tests that measure a blood sugar marker called Hemoglobin A1c as well as other markers. The blood samples are frozen until the end of the study and will be researched at that time. 

Participants may include people at high risk for pancreatic cancer due to the following: 

Study participants will be followed for five years.

Study Site

This Study is Open To:

Men and women age 19 years or older can be considered for enrollment in this study if they meet one of the following criteria:

This Study is Not Open To:


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.